Impact News +++ KULR outlines plan to reach ~10,000 drone battery packs per month in H2 2026 as it targets gross margin... (SeekingAlpha) +++ KULR Aktie -12,98%

Gewinn & Umsatz News zur CHARLES RIVER Aktie

>CHARLES RIVER Aktienkurs

149.975 EUR (TradegateBSX)

Ask: 150.7 EUR / 67 Stück

Bid: 149.25 EUR / 68 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>CHARLES RIVER Performance

1 Woche: +5,2%

1 Monat: -5,5%

3 Monate: -17,4%

6 Monate: +8,4%

1 Jahr: +4,5%

laufendes Jahr: -17,4%

>CHARLES RIVER Aktie

Name:

CHARLES RIVER LABORATORIES

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1598641074 / 939391

Symbol/ Ticker:

RV6 (Frankfurt) / CRL (NYSE)

Kürzel:

FRA:RV6, ETR:RV6, RV6:GR, NYSE:CRL

Index:

S&P500

Webseite:

https://www.criver.com/

Profil:

Charles River Laboratories International, Inc. is a global provider of specialized laboratory services focused on supporting the pharmaceutical and biotechnology industries throughout the drug discovery and development process. As a leading player in..
>Volltext..

Marktkapitalisierung:

6798.29 Mio. EUR

Unternehmenswert:

8877.21 Mio. EUR

Umsatz:

3471.82 Mio. EUR

EBITDA:

781.85 Mio. EUR

Nettogewinn:

-124.8 Mio. EUR

Gewinn je Aktie:

-2.55 EUR

Schulden:

2275.24 Mio. EUR

Liquide Mittel:

185.41 Mio. EUR

Operativer Cashflow:

637.79 Mio. EUR

Bargeldquote:

0.19

Umsatzwachstum:

-12.61%

Gewinnwachstum:

-898.72%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 4.364 USD.

Suchwörter:

CHARLES RIVER

Letzte Datenerhebung:

01.04.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 49.23 Mio. St.

Frei handelbar: 98.74%

Leerverk. Aktien: 7.63%

Rückkaufquote: 4.58%

Mitarbeiter: 19700

Umsatz/Mitarb.: 0.18 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 25.75%

Bewertung:

KGV: -

KGV lG: 14.34

KUV: 1.88

KBV: 2.53

PEG-Ratio: -

EV/EBITDA: 11.35

Rentabilität:

Bruttomarge: 30.52%

Gewinnmarge: -3.59%

Operative Marge: 12.48%

Managementeffizenz:

Gesamtkaprendite: -1.97%

Eigenkaprendite: -4.36%

>Peer Group

Gesundheit

>CHARLES RIVER Chart & Kurs - NYSE

>CHARLES RIVER Gewinn & Umsatz News

18.02.26 - 13:36	Charles River Laboratories International Inc. Q4 Earnings Summary (AFX)
	WASHINGTON (dpa-AFX) - Below are the earnings highlights for Charles River Laboratories International Inc. (CRL):Earnings: -$276.56 million in Q4 vs. -$215.70 million in the same period last year.......

19.01.26 - 13:18	What to Expect From Charles River Laboratories' Next Quarterly Earnings Report (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

05.11.25 - 14:49	Charles River Laboratories Updates FY25 Earnings Outlook (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International, Inc. (CRL), Wednesday an updated financial outlook for fiscal year 2025.The company now anticipates earnings of $4.15 - $4.35 per s......

05.11.25 - 14:49	Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) reported a profit for third quarter that Decreased from last year but beat the Street estimates.The company's bottom line......

27.08.25 - 16:30	Charles River Laboratories Stock: Analyst Estimates & Ratings (Barchart)
	Despite Charles River Laboratories' weak performance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock's prospects....

06.08.25 - 15:18	Charles River Laboratories International Inc. Profit Drops In Q2 (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) revealed earnings for second quarter that Drops, from the same period last yearThe company's earnings came in at $52.32 m......

18.07.25 - 14:18	Heres What to Expect From Charles River Laboratories Next Earnings Report (Barchart)
	Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company's bottom-line figure....

07.05.25 - 15:18	ROUNDUP: Charles River Boosts FY25 Outlook; Stock Up 22% On Strategic Review Announcement (AFX)
	WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) raised its earnings, adjusted earnings, revenue gr......

07.05.25 - 13:48	Charles River Laboratories International Inc. Q1 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) revealed earnings for first quarter that decreased from last year but beat the Street estimates.The company's earnings to......

28.04.25 - 18:30	Earnings Preview: What To Expect From Charles River Laboratories Report (Barchart)
	Charles River Laboratories is scheduled to announce its first-quarter results next week, with analysts anticipating a single-digit earnings dip....

26.02.25 - 10:48	Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance....

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Es gibt einen Tag, um geboren zu werden, und einen Tag, um zu sterben. - China Weisheit

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram